Atherosclerosis Risk Factors Flashcards
Name 3 mechanisms by which smoking affects vascular biology
- Endothelial dysfunction:
* decrases NO, increases reactive oxygen species. Flow mediated dilation diminished. - Prothrombotic:
- increases thromboxane A2, decreases prostacyclin = platelet aggregation
- increases prothrombotic substances like vWF, thrombin and fibrin
- decreases antrithrombotic/fibrinolytic substances like tpa, plasminogen activator inhibitor-1
- Inflammation:
* increases leukocytes, IL-6, CRP, TNF-alpha, IL-1-B
What is the risk of heavy smokers (> 15 cigarettes a day) requiring an amputation after LE bypass compared with non-heavy smokers?
21% vs 2% at 3 years
Name 7 smoking cessation tools. Which is most effective?
- Varenicicline
- Buproprion
- Nicotine patch
- Nicotine gum
- Nicotine inhaler.
- Nicotine losenge
- Nicotine nasal spray
Varinecicline and nicotine patch most effective - abstinence 30-35%
What is the difference between type 1 and type 2 diabetes?
DM1 - Absolute deficiency of insulin secretion, 5-10% of diabetics, cellular mediated auto immune destruction of pancreatic beta cells
DM2 - combination of insulin resistance and inadequate compensatory insulin secretion - heterogeneous etiology
Fill in the blanks


Fill in the blanks


Fill in the blanks


Fill in the blanks


Name 3 large trials that looked at the impact of tight glycemic control (<6.5 %) vs. standard (7-8%) on macrovascular parameters.
What were the findings?
ACCORD, ADVANCE, Veterans Affairs Diabetes Trial.
All failed to demonstrate a reduction in CV outcomes and in fact increased the CV mortality in the ACCORD trial that was stopped early. This is why the treatment recommendation is to target A1c of 7
DDP-4 inhibitors (e.g. sitagliptin)
- What is the mechanism of action
- Expected A1C reduction
- Mechanism of action: inhibit degradation of endogenous GLP-1 thereby enhanceing effect of incretins
- A1C Reduction: 0.6-0.8%

GLP-1 Mimetics (e.g. exenatide)
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Mechanism of action: increases glucose dependent insulin secretion, decrease glucagon, delay gastric emptying
- A1C Reduction: 1%
3 Adverse effects: nausea/vomit

Thiazolidinediones (e.g. rosiglitazone, pioglitazone)
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Mechanism of action: activates PPAR-gamma nucrease receptor which increases peripheral insulin sensitivity and reduces hepatic glucose production
- A1C Reduction: 1-1.5%
3 Adverse effects: weight gain, edema, possible bone loss in women

Alpha - glucosidase inhibitors (e.g. acarbose, miglitol)
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Outcomes/Safety concerns
- Mechanism of action: slows gut carbohydrate reabsorption
- A1C Reduction: 0.5 - 1%
3 Adverse effects: gas, bloating
- Outcome/Safety: Imporves postprandial glucose excursions which may improve CVD

Glinides Nateglinide
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Outcomes/Safety concerns
- Mechanism of action: Bind to sulfonylurea receptors on pancreatic ilset cells stimulating insulin release
- A1C Reduction: 1-2%
3 Adverse effects: Hypoglycemia, weight gain
- Outcome/Safety: Hypoglycemia may precipitate ischemia or arrythmia

Sulfonylureas (e.g. Gliclazide)
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Outcomes/Safety concerns
- Mechanism of action: Bind to sulfonylurea receptors on pancreatic ilset cells stimulating insulin release
- A1C Reduction: 1-2%
3 Adverse effects: Hypoglycemia, weight gain
- Outcome/Safety: Hypoglycemia may precipitate ischemia or arrythmia

Biguanide (Metformin)
- What is the mechanism of action
- Expected A1C reduction
- Adverse effects
- Outcomes
- Safety concerns
- Mechanism of action: Decreases hepatic glucose production
- A1C Reduction: 1-2%
3 Adverse effects: Diarrhea, nausea, lactic acidosis, decreased B12
- Outcome: may improve CVD outcomes
- Contraindicated in decompinsated or unstable heart failure due to lactic acidosis

According to the American Diabetes Association - what is the algorithm for the initiation and adjustment of therapy:
- First step
- Second step
- Third step
- Lifestyle interventions
- Metformin
- If A1c not less than 7 - add sulfonyl urea or insulin
Other OHG relegated to “second tier”
What are very high LDL, low HDL and very high TG according to the Adult Treatment Panel III Guidelines?
LDL >4.9
HDL <1.04
TG >5.65
What is the optimal LDL, HDL and TG according to the Adult Treatment Panel III Guidelines?
LDL < 2.6
HDL >1.55
TG <1.7
What specific lifestyle recommendations can you make for patients to decrease risk associated with fasting lipid profiles?
- LDL Raising nutrient: keep sat fat < 7% and dietary cholesterol <200 mg/day
- LDL Lowering: Plan sterols, soluble fibers, total calories adjusted to prevent weight gain, exercise at least 200 kcal/day
Which landmark trial supports the use of statins in PAD?
HPS - Heart protection study. 6000 patients with PAD showed benefit. Overall 19.8% risk for a first major vascular event on statin vs. 25.2% with placebo - a 24% relative risk reduction.
Which medications block the intestinal absorption of cholesterol (particularly effective when combined with a statin for HLD)
Ezetimibe and bile acid sequesterants. Both can be used esp when patients cannot tolerate max dose of statin.
Name 7 agents used for hyperlipidemia
- Statins
- Ezetimibe
- ER Niacin
- Fenofibrate
- Omega 3
- Bile acid sequestrants
- Cholesterol ester transfer inhibitors
If unable to meet LDL targets in patients with homozygous familial hypercholestorlemia despite maximal diet/therapy, what treatment can you offer?
LDL apheresis is available at some centres. PCSK9 inhibitors may also redule LDL in HFH patients.
According to the JNC-8 (Joint National Committee on Prevention/Detection/Eval/Tx of HTN), what should be the target BP in adults over 60 years old?
< 150/90
What is the criteria for “resistant hypertension”
Uncontrolled BP despite adequate doses of 3 antihypertensives, including a diuretic
Name 9 causes of secondary hypertension
“TOOK A CRAP”
- T - Thyroid disease
- O- OSA
- O - OCP
- K - kidney disease (proteinuria, elevated cr)
- A - Coarctation of aorta
- C - cushing
- R- renal artery stenosis
- A - Primary aldosteronism
- P - Pheochromocytoma
Which part of the kidney does Angiotensin 2 vasoconstrict?
Efferent arterioles
Which study showed that Ramipril lowers cardiovascular risk in patients with PAD?
HOPE study (Heart Outcomes Prevention Evaluation)